论文部分内容阅读
高促性腺激素性性腺功能减退症的诊治进展
【机 构】
：
解放军总医院 100853
【出 处】
：
中华医学会第八次全国内分泌学学术会议
【发表日期】
：
2009年1期
其他文献
A Noval Perixosome Proliferator-activated Receptor-agonist HS060098, Improving both Dislipidemia and
Peraxisome proliferator-activated receptor δ (PPARδ) has rapidly emerged as a potential target in the battle against dyslipidemia,Type Ⅱ diabetes and obesity,with the therapeutic efficacy in the treat
会议
Effects of Nebivolol, a Novel, Highly Selective β1 Adrenergic Receptor Blocker, on Renal Microcircul
Nebivolol is a novel,highly selective β1 adrenergic blocker currently used in clinical practice.However,there is less information regarding its effects on renal microcirculation.The aim of the present
会议
Over the past decade,fragment based drug design has emerged as an alterative approach for drug discovery.It is a process whereby small but highly efficient ligands (fragments) are identified and then
会议
Development and NMR Validation of Minimal Pharmacophore Hypotheses for the Generation of Fragment Li
A combined strategy based on the development of pharmacophore hypotheses and NMR approaches is reported for the identification of novel inhibitors of heparanase,a key enzyme involved in tumor metastas
会议
Intersection of Biophysical Studies and Drug Design.Use of the “Efficiency Coefficient” and “Drug De
As we all know,the NCE that reach market have been dwindling even though our ability to use technology has increased.This might be due to the fact that all the easy targets are well studied and only t
会议